483 Document: Cangene bioPharma, Inc. dba Emergent BioSolutions, Apr 9, 2014

FDAzilla 483 Cangene bioPharma, Inc. dba Emergent BioSolutions Apr 9 2014 top
FDAzilla 483 Cangene bioPharma, Inc. dba Emergent BioSolutions Apr 9 2014 bottom

On Apr 09, 2014, the FDA inspected Cangene bioPharma, Inc. dba Emergent BioSolutions's Baltimore site. Explore the inspectional observations.